Matthew Tremblay

453 total citations
12 papers, 323 citations indexed

About

Matthew Tremblay is a scholar working on Pathology and Forensic Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Matthew Tremblay has authored 12 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 4 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Matthew Tremblay's work include Multiple Sclerosis Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Immunotherapy and Immune Responses (2 papers). Matthew Tremblay is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Immunotherapy and Immune Responses (2 papers). Matthew Tremblay collaborates with scholars based in United States, Switzerland and Mexico. Matthew Tremblay's co-authors include Christopher M. Acker, Peter Davies, Sarah D. Schlatterer, Ilya Kister, Jeffrey M. Gelfand, Elizabeth Crabtree‐Hartman, Gregory M. Marcus, Diane D. Allen, Pierre‐Antoine Gourraud and Antoine Lizée and has published in prestigious journals such as Neurology, Journal of the Neurological Sciences and Journal of Alzheimer s Disease.

In The Last Decade

Matthew Tremblay

11 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Tremblay United States	7	109	88	87	81	54	12	323
Constantinos Sfagos Greece	10	111 1.0×	60 0.7×	43 0.5×	86 1.1×	36 0.7×	17	309
Young Nam Kwon South Korea	10	87 0.8×	83 0.9×	85 1.0×	130 1.6×	24 0.4×	36	330
Gordana Tončev Serbia	8	133 1.2×	62 0.7×	23 0.3×	67 0.8×	45 0.8×	23	304
Е. И. Гусев Russia	14	145 1.3×	83 0.9×	50 0.6×	102 1.3×	68 1.3×	67	550
Anna Jeong United States	12	51 0.5×	60 0.7×	66 0.8×	112 1.4×	58 1.1×	22	346
Petra Lelková Czechia	8	132 1.2×	105 1.2×	68 0.8×	32 0.4×	16 0.3×	9	341
Eleonora Mauri Italy	7	30 0.3×	76 0.9×	83 1.0×	80 1.0×	50 0.9×	22	332
Maged Abdel Naseer Egypt	11	84 0.8×	42 0.5×	34 0.4×	45 0.6×	17 0.3×	28	282
Nadia Tenenbaum United States	11	234 2.1×	80 0.9×	42 0.5×	90 1.1×	15 0.3×	21	369
Jorge Millán‐Pascual Spain	13	167 1.5×	62 0.7×	20 0.2×	150 1.9×	11 0.2×	28	394

Countries citing papers authored by Matthew Tremblay

Since Specialization

Citations

This map shows the geographic impact of Matthew Tremblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Tremblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Tremblay more than expected).

Fields of papers citing papers by Matthew Tremblay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Tremblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Tremblay. The network helps show where Matthew Tremblay may publish in the future.

Co-authorship network of co-authors of Matthew Tremblay

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Tremblay. A scholar is included among the top collaborators of Matthew Tremblay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Tremblay. Matthew Tremblay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Tremblay, Matthew, et al.. (2023). Real-World Efficacy of COVID-19 Pre-Exposure Prophylaxis with Tixagevimab/Cilgavimab in People with Multiple Sclerosis. Vaccines. 11(12). 1855–1855. 3 indexed citations

Mendoza, Jason P., et al.. (2023). COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy. Neurology and Therapy. 12(2). 687–700. 8 indexed citations

Tremblay, Matthew, et al.. (2023). Vaccine response in people with multiple sclerosis treated with fumarates. Multiple Sclerosis Journal - Experimental Translational and Clinical. 9(3). 3100554370–3100554370. 3 indexed citations

Zhang, Yan, et al.. (2020). Neurosarcoidosis presenting as limbic encephalitis (5431). Neurology. 94(15_supplement).

Tremblay, Matthew, et al.. (2020). Advances in the Treatment of Neuromyelitis Optica Spectrum Disorder. Neurologic Clinics. 39(1). 35–49. 29 indexed citations

Tremblay, Matthew, Javier Villanueva-Meyer, Soonmee Cha, Tarık Tihan, & Jeffrey M. Gelfand. (2017). Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions. Journal of the Neurological Sciences. 381. 83–87. 12 indexed citations

Block, Valerie J., Antoine Lizée, Elizabeth Crabtree‐Hartman, et al.. (2017). Continuous Daily Assessment Of Multiple Sclerosis Disability Using Remote Step Count Monitoring (P1.376). Neurology. 88(16_supplement). 1 indexed citations

Manwani, Bharti, et al.. (2017). HSV Encephalitis associated with off-label Rituximab use in a case of relapsing multiple sclerosis. (P5.390). Neurology. 88(16_supplement). 1 indexed citations

Block, Valerie J., Antoine Lizée, Elizabeth Crabtree‐Hartman, et al.. (2016). Continuous daily assessment of multiple sclerosis disability using remote step count monitoring. Journal of Neurology. 264(2). 316–326. 106 indexed citations

10.

Pierson, Tyler Mark, Matthew Tremblay, Richard A. Lewis, et al.. (2015). Adult-onset glutaric aciduria type I presenting with white matter abnormalities and subependymal nodules. Neurogenetics. 16(4). 325–328. 20 indexed citations

11.

Schlatterer, Sarah D., Matthew Tremblay, Christopher M. Acker, & Peter Davies. (2011). Neuronal c-Abl Overexpression Leads to Neuronal Loss and Neuroinflammation in the Mouse Forebrain. Journal of Alzheimer s Disease. 25(1). 119–133. 55 indexed citations

12.

Tremblay, Matthew, Christopher M. Acker, & Peter Davies. (2010). Tau Phosphorylated at Tyrosine 394 is Found in Alzheimer's Disease Tangles and can be a Product of the Abl-Related Kinase, Arg. Journal of Alzheimer s Disease. 19(2). 721–733. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact